Ohcanbohtosat - Astrid Gruber
- Čájehuvvo 1 - 14 / 14
-
1
-
2
-
3
Switch from Myc/Max to Mad1/Max binding and decrease in histone acetylation at the <i>telomerase reverse transcriptase</i> promoter during differentiation of HL60 cells Dahkki Dawei Xu, Nikita Popov, Mi Hou, Qian Wang, Magnus Björkholm, Astrid Gruber, Annette R. Menkel, Marie Arsenian‐Henriksson
Almmustuhtton 2001Artigo -
4
KI-67 AND hTERT Expression Can Aid in the Distinction between Malignant and Benign Pheochromocytoma and Paraganglioma Dahkki Elisabeth Elder, Dawei Xu, Anders Höög, Ulla Enberg, Mi Hou, Pavel Pisa, Astrid Gruber, Catharina Larsson, Martin Bäckdahl
Almmustuhtton 2003Artigo -
5
The <i>Telomerase Reverse Transcriptase</i> (<i>hTERT</i>) Gene Is a Direct Target of the Histone Methyltransferase SMYD3 Dahkki Cheng Liu, Xiaolei Fang, Zheng Ge, Marit Jalink, Satoru Kyo, Magnus Björkholm, Astrid Gruber, Jan Sjöberg, Dawei Xu
Almmustuhtton 2007Artigo -
6
-
7
Infectious complications and NK cell depletion following daratumumab treatment of Multiple Myeloma Dahkki Hareth Nahi, Michael Chrobok, Charlotte Gran, Johan Lund, Astrid Gruber, Gösta Gahrton, Per Ljungman, Arnika Kathleen Wagner, Evren Alici
Almmustuhtton 2019Artigo -
8
The N-terminal Region of Comparative Gene Identification-58 (CGI-58) Is Important for Lipid Droplet Binding and Activation of Adipose Triglyceride Lipase Dahkki Astrid Gruber, Irina Cornaciu, Achim Lass, Martina Schweiger, M. POESCHL, Christina Eder, Manju Kumari, Gabriele Schoiswohl, Heimo Wolinski, Sepp D. Kohlwein, Rudolf Zechner, Robert Zimmermann, Monika Oberer
Almmustuhtton 2010Artigo -
9
The Minimal Domain of Adipose Triglyceride Lipase (ATGL) Ranges until Leucine 254 and Can Be Activated and Inhibited by CGI-58 and G0S2, Respectively Dahkki Irina Cornaciu, Andras Boeszoermenyi, Hanna Lindermuth, Harald M. Nagy, Ines K. Cerk, Catharina Ebner, Barbara Salzburger, Astrid Gruber, Martina Schweiger, Rudolf Zechner, Achim Lass, Robert Zimmermann, Monika Oberer
Almmustuhtton 2011Artigo -
10
Tandem Autologous/Reduced-Intensity Conditioning Allogeneic Stem-Cell Transplantation Versus Autologous Transplantation in Myeloma: Long-Term Follow-Up Dahkki Bo Björkstrand, Simona Iacobelli, Ute Hegenbart, Astrid Gruber, Hildegard Greinix, Liisa Volin, Franco Narni, Pellegrino Musto, Meral Beksaç, Alberto Bosi, Giuseppe Milone, Paolo Corradini, Hartmut Goldschmidt, Théo de Witte, Curly Morris, Dietger Niederwieser, Gösta Gahrton
Almmustuhtton 2011Artigo -
11
Sorafenib Has Potent Antitumor Activity against Multiple Myeloma <i>In Vitro</i>, <i>Ex Vivo</i>, and <i>In Vivo</i> in the 5T33MM Mouse Model Dahkki Pedram Kharaziha, Hendrik De Raeve, Charlotte Fristedt, Qiao Li, Astrid Gruber, Per Johnsson, Georgia Kokaraki, Maria Panzar, Edward Laane, Anders Österborg, Boris Zhivotovsky, Helena Jernberg‐Wiklund, Dan Grandér, Fredrik Celsing, Magnus Björkholm, Karin Vanderkerken, Theocharis Panaretakis
Almmustuhtton 2012Artigo -
12
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study Dahkki Gösta Gahrton, Simona Iacobelli, Bo Björkstrand, Ute Hegenbart, Astrid Gruber, Hildegard Greinix, Liisa Volin, Franco Narni, Angelo Michele Carella, Meral Beksaç, Alberto Bosi, Giuseppe Milone, Paolo Corradini, Stefan Schönland, Kristina Friberg, Anja van Biezen, Hartmut Goldschmidt, Théo de Witte, Curly Morris, Dietger Niederwieser, Laurent Garderet, Nicolaus Kröger
Almmustuhtton 2013Artigo -
13
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial Dahkki Ulf‐Henrik Mellqvist, Peter Gimsing, Øyvind Hjertner, Stig Lenhoff, Edward Laane, Kari Remes, Hlíf Steingrímsdóttir, Niels Abildgaard, Lucia Ahlberg, Cecilie Blimark, Inger Marie S. Dahl, Karin Forsberg, Tobias Gedde‐Dahl, Henrik Gregersen, Astrid Gruber, Nina Guldbrandsen, Einar Haukås, Kristina Carlson, Ann Kristin Kvam, Hareth Nahi, Roald Lindås, Niels Frost Andersen, Ingemar Turesson, Anders Waage, Jan Westin
Almmustuhtton 2013Artigo -
14
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma Dahkki Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist, Morten Salomo, Gerard M.J. Bos, Mark‐David Levin, Heleen Visser-Wisselaar, Markus Hansson, Annette W.G. van der Velden, Wendy Deenik, Astrid Gruber, J.L. Coenen, Torben Plesner, Saskia K. Klein, Bea C. Tanis, Damian Szatkowski, Rolf E. Brouwer, Matthijs Westerman, Mark Leys, Harm Sinnige, Einar Haukås, K.G. van der Hem, Marc Durian, E. J. M. Mattijssen, Niels W.C.J. van de Donk, Marian Stevens‐Kroef, Pieter Sonneveld, Anders Waage
Almmustuhtton 2016Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Medicine
Internal medicine
Biochemistry
Gene
Genetics
Multiple myeloma
Chemistry
Molecular biology
Telomerase
Autologous stem-cell transplantation
Cancer research
Cell biology
Melphalan
Oncology
Surgery
Telomerase reverse transcriptase
Transplantation
Adipose tissue
Adipose triglyceride lipase
Antibody
Chemotherapy
Chromatin immunoprecipitation
Engineering
Enzyme
Gastroenterology
Gene expression
Histone
Immunology
Lipase